Abstract
Off-pump coronary artery bypass grafting (OPCAB) avoids the deleterious systemic inflammatory effects of the extracorporeal circuit. When a patient must pay all treatment expenses, cost cutting becomes very important to the treating surgeon. Considering both factors, an Acrobat-SUV heart stabiliser was used in the first 110 OPCAB patients to keep the expenditure minimal; the results were analysed at the end of 5 years.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call